Insulin Management Software Wins FDA Nod

Insulin Algorithms was granted FDA clearance for their software designed to aid clinicians in managing insulin doses for their patients with diabetes.

The new software is based on clinically proven algorithms designed to lower blood sugar. Clinicians will use it to analyze their patient’s blood sugar measurements on a consistent basis and draw conclusions from the results that will better optimize their patient’s insulin intake.

With this clearance, the company also has CE Mark clearance and can sell their product internationally in Europe and America.